Veru Announces Presentation of Phase 2 Study of Enobosarm — a Selective Androgen Receptor Targeting Agent in Metastatic AR+ER+HER2- Breast Cancer at 2021 ESMO Breast Cancer Congress

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Paul Theisen
Patient Acquisition

David Linetsky
Patient Activation

Frank Burrell
Scientific Storytelling

Thomas Shea
Programmatic Marketing

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Frank X. Powers
Healthcare Challenger Brands

Mike Viscel
Increasing Engagement

Laura Blair
Medication Adherence

Anil Bhaskar
Unified Customer Experience